MediFind found 7 doctor with experience in Lipogranulomatosis near Brittany, FR. Of these, 4 are Advanced, 2 are Experienced and 1 are Distinguished.
Thierry Levade practices in Toulouse, France. Mr. Levade is rated as a Distinguished expert by MediFind in the treatment of Lipogranulomatosis. His top areas of expertise are Lipogranulomatosis, Farber Lipogranulomatosis, Niemann-Pick Disease, Acid Sphingomyelinase Deficiency (ASMD), and Bone Marrow Transplant.
Virginie Garcia practices in Toulouse, France. Ms. Garcia is rated as an Advanced expert by MediFind in the treatment of Lipogranulomatosis. Her top areas of expertise are Lipogranulomatosis, Farber Lipogranulomatosis, Myoclonic Epilepsy, and Primary Lateral Sclerosis.
Stephane Carpentier practices in Toulouse, France. Ms. Carpentier is rated as an Advanced expert by MediFind in the treatment of Lipogranulomatosis. Her top areas of expertise are Lipogranulomatosis, Progressive Myoclonic Epilepsy, Farber Lipogranulomatosis, and Melanoma.
Pauline Le Faouder practices in Toulouse, France. Ms. Le Faouder is rated as an Advanced expert by MediFind in the treatment of Lipogranulomatosis. Her top areas of expertise are Cerebellum Agenesis Hydrocephaly, Lipogranulomatosis, Irritable Bowel Syndrome (IBS), and Acute Pain.
Aude Dupuy practices in Toulouse, France. Ms. Dupuy is rated as an Advanced expert by MediFind in the treatment of Lipogranulomatosis. Her top areas of expertise are Cerebellum Agenesis Hydrocephaly, Lipogranulomatosis, Farber Lipogranulomatosis, and Interstitial Nephritis.
Frederique Sabourdy practices in Toulouse, France. Ms. Sabourdy is rated as an Experienced expert by MediFind in the treatment of Lipogranulomatosis. Her top areas of expertise are Visceromegaly, Myoclonic Epilepsy, Refsum Disease, and Primary Lateral Sclerosis.
Justine Michel-Bertrand practices in Toulouse, France. Ms. Michel-Bertrand is rated as an Experienced expert by MediFind in the treatment of Lipogranulomatosis. Her top areas of expertise are Cerebellum Agenesis Hydrocephaly, Non-Alcoholic Fatty Liver Disease, Obesity, and Irritable Bowel Syndrome (IBS).
Last Updated: 01/09/2026